Copyright
©The Author(s) 2022.
World J Stem Cells. Aug 26, 2022; 14(8): 658-679
Published online Aug 26, 2022. doi: 10.4252/wjsc.v14.i8.658
Published online Aug 26, 2022. doi: 10.4252/wjsc.v14.i8.658
Ref. | HSC donor | MSC donor | Host | Conditioning | Source | Dose (Gy) | MSC immunogenicity | Groups |
Lee et al[9] | Mice (C57BL/6) | Human | Mice (BALB/c H-2d) | Chemotherapy | Bu/Cy | 25 mg/kg/4 d | Xenogeneic | Control; HSC; HSC + T-MSC; HSC + MMP3kdT-MSC |
100 mg/kg/2 d | ||||||||
Huang et al[10] | Human | Human | Mice (NOD/SCID) | TBI | 60-Co | 2.7 | Xenogeneic | Control; HSC; HSC + UCB-MSC (IV/IB) |
Yin et al[8] | Human | Human | Mice (NOD/SCID; NOG) | TBI | NR | 2.5 | Xenogeneic | HSC; HSC + GFP-MSC; HSC + EGF-MSC; HSC + FGF2-MSC; HSC + PDGFB-MSC (IV/IB) |
Choi et al[11] | Mice (C57BL/6) | Human | Mice (BALB/c) | Chemotherapy | Bu/Cy | 20 mg/kg/4 d | Xenogeneic | Control; HSC; HSC + T-MSC |
100 mg/kg/2 d | ||||||||
Trento et al[12] | Mice (C57BL/6 CD45.1) | Mice (C57BL/6 CD45.2 orNos2-/-) | Mice (C57BL/6 CD45.2) | TBI | NR | 8 | Allogeneic | HSC; HSC + MSC; HSC + Nos2−/−MSC |
Abbuehl et al[13] | Mice (FVB Actin-GFP) | Mice (FVB Insulin-GFP) | Mice (FVB Insulin-GFP) | TBI | NR | 2 × 4.5 | Allogeneic | HSC; HSC + MSC |
Kim et al[14] | Mice (C57BL/6J-Pep3b-Ly5.1 Pep3b) | Mice (C57BL/6J-Ly 5.2 BL6) | Mice (C57BL/6J-Ly 5.2 BL6) | TBI | NR | 9 | Xenogeneic | HSC; HSC + MSC (NSS/SS) direct or priming |
Futrega et al[15] | Human | Human | Mice (NSG) | TBI | 137-Cs | 2.5 | Xenogeneic | HSC (IV/IB); HSC + MSC; HSC + MSC-spheroids (IB) |
van der Garde et al[16] | Human | Human | Mice (NOD/SCID) | TBI | NR | 3.5 | Xenogeneic | HSC; HSC + MSC; Ex/TPO-HSC; Ex/TPO-HSC + MSC |
Fernández-García et al[17] | Mice (P3D2F1 H2b/d CD45.1) | Mice (B6D2F1,H2b/d, CD45.2) | Mice (B6D2F CD45.2) | TBI | NR | 5-7 | Allogeneic | HSC; HSC + AT-MSC |
Chen et al[18] | Mice (C57BL/6) | Mice (C57BL/6) | Mice (BALB/c H-2d) | TBI | 60-Co | 7.5 | Allogeneic | HSC; HSC + EGFP-MSC; HSC + CXCR4-MSC |
Chen et al[19] | Human | Human | Mice (NOD/SCID/IL2rγnull) | TBI | 60-Co | 3.5 | Xenogeneic | Control; HSC; HSC + MSC; HSC + SDF-1-MSC; HSC + HOXB4-MSC; HSC + SDF1-HOXB4-MSC |
Wu et al[20] | Human | Human | Mice (NOD/SCID) | TBI | NR | 3.5 | Xenogeneic | HSC; HSC + UCB-MSC |
Lim et al[21] | Human | Human | Mice (NOD/SCID) | TBI | Cs | 2.5 | Xenogeneic | HSC; HSC + hPTH; HSC + UCB-MSC + hPTH |
Lee et al[22] | Human | Human | Mice (NOD/SCID) | TBI | NR | 3 | Xenogeneic | HSC; HSC + BM-MSC; HSC + AT-MSC; HSC + UCB-MSC |
Kornblit et al[23] | Dog (beagle) | Dog (beagle) | Dog (Beagle) | TBI | 60-Co | 9.2 | Allogeneic | Control; HSC; HSC + MSC (unrelated or DLA-id MSC) |
Fortin et al[24] | Mice (B6.SJL-PtrcaPep3b/BoyJ CD45.1) | Mice | Mice (C57BL/6J) | TBI | 60-Co | 8 | Allogeneic | HSC; HSC + MSC; HSC + solG-CSFR-MSC |
Carrancio et al[25] | Human | Human | Mice (NOD/SCID) | TBI | Cs | 3 | Xenogeneic | HSC (IV/IB); HSC IV + MSC (IV/IB) |
- Citation: Garrigós MM, de Oliveira FA, Nucci MP, Nucci LP, Alves ADH, Dias OFM, Gamarra LF. How mesenchymal stem cell cotransplantation with hematopoietic stem cells can improve engraftment in animal models. World J Stem Cells 2022; 14(8): 658-679
- URL: https://www.wjgnet.com/1948-0210/full/v14/i8/658.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v14.i8.658